115 related articles for article (PubMed ID: 11772701)
1. High choline concentrations in the caudate nucleus in antipsychotic-naive patients with schizophrenia.
Bustillo JR; Rowland LM; Lauriello J; Petropoulos H; Hammond R; Hart B; Brooks WM
Am J Psychiatry; 2002 Jan; 159(1):130-3. PubMed ID: 11772701
[TBL] [Abstract][Full Text] [Related]
2. 1H MRSI evidence of metabolic abnormalities in childhood-onset schizophrenia.
O'Neill J; Levitt J; Caplan R; Asarnow R; McCracken JT; Toga AW; Alger JR
Neuroimage; 2004 Apr; 21(4):1781-9. PubMed ID: 15050598
[TBL] [Abstract][Full Text] [Related]
3. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
4. Heritability heightens brain metabolite differences in schizophrenia.
Fukuzako H
J Neuropsychiatry Clin Neurosci; 2000; 12(1):95-7. PubMed ID: 10678520
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced parkinsonism in relation to choline-containing compounds measured by 1H-MR spectroscopy in putamen of chronically medicated patients with schizophrenia.
Yamasue H; Fukui T; Fukuda R; Kasai K; Iwanami A; Kato N; Kato T
Int J Neuropsychopharmacol; 2003 Dec; 6(4):353-60. PubMed ID: 14604450
[TBL] [Abstract][Full Text] [Related]
6. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia.
Deicken RF; Zhou L; Schuff N; Weiner MW
Schizophr Res; 1997 Oct; 27(1):65-71. PubMed ID: 9373896
[TBL] [Abstract][Full Text] [Related]
7. Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia.
Fujimoto T; Nakano T; Takano T; Takeuchi K; Yamada K; Fukuzako T; Akimoto H
Biol Psychiatry; 1996 Jul; 40(1):14-8. PubMed ID: 8780850
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy during initial treatment with antipsychotic medication in schizophrenia.
Bustillo JR; Rowland LM; Jung R; Brooks WM; Qualls C; Hammond R; Hart B; Lauriello J
Neuropsychopharmacology; 2008 Sep; 33(10):2456-66. PubMed ID: 18094668
[TBL] [Abstract][Full Text] [Related]
9. Metabolic alterations in medication-free patients with bipolar disorder: a 3T CSF-corrected magnetic resonance spectroscopic imaging study.
Port JD; Unal SS; Mrazek DA; Marcus SM
Psychiatry Res; 2008 Feb; 162(2):113-21. PubMed ID: 18164911
[TBL] [Abstract][Full Text] [Related]
10. Quantitative magnetic resonance spectroscopy of schizophrenia: relationship between decreased N-acetylaspartate and frontal lobe dysfunction.
Tanaka Y; Obata T; Sassa T; Yoshitome E; Asai Y; Ikehira H; Suhara T; Okubo Y; Nishikawa T
Psychiatry Clin Neurosci; 2006 Jun; 60(3):365-72. PubMed ID: 16732755
[TBL] [Abstract][Full Text] [Related]
11. Duration of untreated psychosis vs. N-acetylaspartate and choline in first episode schizophrenia: a 1H magnetic resonance spectroscopy study at 4.0 Tesla.
Théberge J; Al-Semaan Y; Drost DJ; Malla AK; Neufeld RW; Bartha R; Manchanda R; Menon R; Densmore M; Schaefer B; Williamson PC
Psychiatry Res; 2004 Jul; 131(2):107-14. PubMed ID: 15313517
[TBL] [Abstract][Full Text] [Related]
12. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS.
Théberge J; Al-Semaan Y; Williamson PC; Menon RS; Neufeld RW; Rajakumar N; Schaefer B; Densmore M; Drost DJ
Am J Psychiatry; 2003 Dec; 160(12):2231-3. PubMed ID: 14638596
[TBL] [Abstract][Full Text] [Related]
13. Regarding "Increased prefrontal and hippocampal glutamate concentration in schizophrenia: evidence from a magnetic resonance spectroscopy study".
Théberge J; Jensen JE; Rowland LM
Biol Psychiatry; 2007 May; 61(10):1218-9; author reply 1219-20. PubMed ID: 16950227
[No Abstract] [Full Text] [Related]
14. Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study.
Gabbay V; Hess DA; Liu S; Babb JS; Klein RG; Gonen O
Am J Psychiatry; 2007 Dec; 164(12):1881-9. PubMed ID: 18056244
[TBL] [Abstract][Full Text] [Related]
15. Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia.
Deicken RF; Johnson C; Eliaz Y; Schuff N
Am J Psychiatry; 2000 Apr; 157(4):644-7. PubMed ID: 10739431
[TBL] [Abstract][Full Text] [Related]
16. Brain magnetic resonance spectroscopy in Tourette's disorder.
DeVito TJ; Drost DJ; Pavlosky W; Neufeld RW; Rajakumar N; McKinlay BD; Williamson PC; Nicolson R
J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1301-8. PubMed ID: 16292123
[TBL] [Abstract][Full Text] [Related]
17. Detection of metabolites in the white matter of frontal lobes and hippocampus with proton in first-episode treatment-naïve schizophrenia patients.
He ZL; Deng W; Li ML; Chen ZF; Collier DA; Ma X; Li T
Early Interv Psychiatry; 2012 May; 6(2):166-75. PubMed ID: 21951785
[TBL] [Abstract][Full Text] [Related]
18. Decreased left frontal lobe N-acetylaspartate in schizophrenia.
Deicken RF; Zhou L; Corwin F; Vinogradov S; Weiner MW
Am J Psychiatry; 1997 May; 154(5):688-90. PubMed ID: 9137129
[TBL] [Abstract][Full Text] [Related]
19. A 1H-MRS investigation of the medial temporal lobe in antipsychotic-naïve and early-treated first episode psychosis.
Wood SJ; Berger GE; Wellard RM; Proffitt T; McConchie M; Velakoulis D; McGorry PD; Pantelis C
Schizophr Res; 2008 Jul; 102(1-3):163-70. PubMed ID: 18456460
[TBL] [Abstract][Full Text] [Related]
20. Frontal white matter biochemical abnormalities in late-life major depression detected with proton magnetic resonance spectroscopy.
Kumar A; Thomas A; Lavretsky H; Yue K; Huda A; Curran J; Venkatraman T; Estanol L; Mintz J; Mega M; Toga A
Am J Psychiatry; 2002 Apr; 159(4):630-6. PubMed ID: 11925302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
